Ingredients by Nature receives patent approval for use of eriocitrin to support blood glucose
The U.S. Patent and Trademark Office has approved a patent for the use of eriocitrin in Ingredient By Nature’s ingredient formulations, such as Eriomin, a citrus flavonoid designed for blood glucose support.
Photo © iStockphoto.com/eli_asenova
The U.S. Patent and Trademark Office has approved a patent for the use of eriocitrin in Ingredient By Nature’s (IBN; Montclair, CA) ingredient formulations, such as Eriomin, a citrus flavonoid designed for blood glucose support. The specific patent claim states that eriocitrin can be used as, “A method of reducing blood glucose levels in a human subject in need thereof, comprising administering to the subject a composition comprising 100-200 mg eriocitrin once per day.”
“We couldn’t be happier with the progress we have made to recognize eriocitrin as a viable option for better health,” said Rob Brewster, president of IBN, in a press release. “Supported by a successful first clinical trial and now this patent, our line of Eriomin lemon flavonoid blends, which are primarily comprised of eriocitrin, provide powerful support to managing healthy blood glucose levels. We look forward to revealing additional significant results from ongoing research into the effect that eriocitrin can have on blood glucose levels later this year.”
FDA revokes authorization to use Red No. 3 as a color additive in food or drugs
January 15th 2025FDA contends that the color additive is safe for humans but is legally obligated by the Delaney Clause of the FD&C act to revoke authorization as research shows the Red No. 3 induces cancer in rats.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
